Dr. Jan Buckner is a medical oncologist in Rochester, Minnesota. He got his medical degree from University of North Carolina at Chapel Hill School of Medicine and did his residency at Spectrum Health-Butterworth Campus. Dr. Buckner went to Mayo School of Graduate Medical Education and obtained his fellowship in medical oncology. He is certified by the American board in both medical oncology and internal medicine. Dr. Buckner has over 20 years of experience and is currently affiliated with Mayo Clinic – Rochester.
University of North Carolina at Chapel Hill School of Medicine
Spectrum Health-Butterworth Campus
Mayo School of Graduate Medical Education
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas.
Korfiatis, P.,Kline, T. L.,Coufalova, L.,Lachance, D. H.,Parney, I. F.,Carter, R. E.,Buckner, J. C.,Erickson, B. J.; Med Phys.See more >>
Pragmatic study designs for older adults with cancer: Report from the U13 conference.
Nipp, R. D.,Yao, N. A.,Lowenstein, L. M.,Buckner, J. C.,Parker, I. R.,Gajra, A.,Morrison, V. A.,Dale, W.,Ballman, K. V.; J Geriatr Oncol.See more >>
Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance).
Brown, P. D.,Anderson, S. K.,Carrero, X. W.,O\'Neill, B. P.,Giannini, C.,Galanis, E.,Shah, S. A.,Abrams, R. A.See more >>
Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure.
Berg, A. K.,Buckner, J. C.,Galanis, E.,Jaeckle, K. A.,Ames, M. M.,Reid, J. M.; J Clin PharmacolSee more >>
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma:
NCCTG N057K. Ma, D. J.,Galanis, E.,Anderson, S. K.,Schiff, D.,Kaufmann, T. J.,Peller, P. J.,Giannini, C.,Brown, P. D.,Uhm, J. H.,McGraw, S.,JaeckSee more >>
American Society of Clinical Oncology